Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.

Neuro-oncology - 1 Dec 2022

Felix Marius, Friedel Dennis, Jayavelu Ashok Kumar, Filipski Katharina, Reinhardt Annekathrin, Warnken Uwe, Stichel Damian, Schrimpf Daniel, Korshunov Andrey, Wang Yueting, Kessler Tobias, Etminan Nima, Unterberg Andreas, Herold-Mende Christel, Heikaus Laura, Sahm Felix, Wick Wolfgang, Harter Patrick N, von Deimling Andreas, Reuss David E

Abstract excerpt

BACKGROUND: IDH-mutant gliomas are separate based on the codeletion of the chromosomal arms 1p and 19q into oligodendrogliomas IDH-mutant 1p/19q-codeleted and astrocytomas IDH-mutant. While nuclear loss of ATRX expression excludes 1p/19q codeletion, its limited sensitivity prohibits to conclude on 1p/19q status in tumors with retained nuclear ATRX expression. METHODS: Employing mass spectrometry based proteomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Oligodendroglioma
Share to Astrocytoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 1

Share to Chromosomes, Human, Pair 19

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Microfilament Proteins

Share to Vimentin

Source

Open in PubMed Open full text

Identifiers

PMID: 35511748
DOI: 10.1093/neuonc/noac111
PMCID: PMC9713528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.PMID 35511748Read ↗

Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion.Semantic proximity Read ↗

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.Semantic proximity Read ↗

IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.Semantic proximity Read ↗

Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.Semantic proximity Read ↗

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.Semantic proximity Read ↗

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.Semantic proximity Read ↗

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.Semantic proximity Read ↗

Alpha Internexin: A Surrogate Marker for 1p/19q Codeletion and Prognostic Marker in Anaplastic (WHO grade III) Gliomas.Semantic proximity Read ↗

The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.Semantic proximity Read ↗

Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.Semantic proximity Read ↗

Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH.Semantic proximity Read ↗

1p/19q testing has no significance in the workup of glioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.